Loading organizations...
Loading organizations...
Biopharmaceutical company developing oncology therapeutic technologies.
Tigris Pharmaceuticals has raised $6.5M across 1 funding round.
Tigris Pharmaceuticals has raised $6.5M in total across 1 funding round.
Tigris Pharmaceuticals has raised $6.5M in total across 1 funding round.
Tigris Pharmaceuticals's investors include Neil Flanzraich, Sonostar Capital Partners, Wexford Capital.
Tigris Pharmaceuticals has raised $6.5M across 1 funding round. Most recently, it raised $6.5M Series C in September 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 28, 2010 | $6.5M Series C | Neil Flanzraich | Sonostar Capital Partners, Wexford Capital |